赵秋兰, 邢金梅, 崔秀卿, 刘华. 血清脂肪因子visfatin、A-FABP与老年高血压血压变异性的相关性[J]. 心脏杂志, 2019, 31(5): 539-543. DOI: 10.12125/j.chj.201905055
    引用本文: 赵秋兰, 邢金梅, 崔秀卿, 刘华. 血清脂肪因子visfatin、A-FABP与老年高血压血压变异性的相关性[J]. 心脏杂志, 2019, 31(5): 539-543. DOI: 10.12125/j.chj.201905055
    Qiu-lan ZHAO, Jin-mei XING, Xiu-qing CUI, Hua LIU. Correlation between serum visfatin, A-FABP and blood pressure variability in elderly patients with hypertension[J]. Chinese Heart Journal, 2019, 31(5): 539-543. DOI: 10.12125/j.chj.201905055
    Citation: Qiu-lan ZHAO, Jin-mei XING, Xiu-qing CUI, Hua LIU. Correlation between serum visfatin, A-FABP and blood pressure variability in elderly patients with hypertension[J]. Chinese Heart Journal, 2019, 31(5): 539-543. DOI: 10.12125/j.chj.201905055

    血清脂肪因子visfatin、A-FABP与老年高血压血压变异性的相关性

    Correlation between serum visfatin, A-FABP and blood pressure variability in elderly patients with hypertension

    • 摘要:
        目的  探讨血清visfatin、A-FABP与老年高血压血压变异性(BPV)相关性。
        方法  选取2017年1月至2019年2月保定市第二医院收治的老年高血压患者(≥ 60岁)235例,采用ELISA法检测血清visfatin、A-FABP水平,分析不同水平组visfatin、A-FABP与老年高血压24 h平均动脉压(24 hMABP)、24 h舒张压变异率(24 hDBPV)、24 h收缩压变异率(24 hSBPV)的相关性。
        结果  采用最大选择检验法确定血清visfatin、A-FABP的截断点分别为43.5 ng/ml、20.9 ng/ml,visfatin低水平组的24 hMABP、24 hDBPV、24 hSBPV较高水平组明显降低(均P < 0.01)。A-FABP低水平组24 hDBPV、24 hSBPV、visfatin显著低于高水平组(均P<0.01)。24 hSBPV与年龄、LDL-C、血清visfatin、血清A-FABP呈正相关(均P < 0.01)。24 hDBPV与年龄、血清visfatin、血清A-FABP呈正相关(均P < 0.01)。
        结论  年龄、A-FABP、visfatin是BPV增高的独立相关因素。

       

      Abstract:
        AIM  To investigate the correlation between serum visfatin, A-FABP and blood pressure variability in elderly patients with hypertension.
        METHODS  235 elderly patients with hypertension (> 60 years old) admitted to Baoding Second Hospital from January 2017 to February 2019 were selected. Serum visfatin and A-FABP levels were measured by ELISA. The correlation between visfatin and A-FABP and 24-hour mean arterial pressure (24-hour MABP), 24-hour diastolic pressure variability (24-hour DBPV) and 24-hour systolic pressure variability (24-hour SBPV) was analyzed.
        RESULTS  The optimum threshold values of serum visfatin and A-FABP were 43.5 ng/ml and 20.9 ng/ml respectively. The 24-hour MABP, 24-hour DBPV and 24-hour SBPV in the group of visfatin < 43.5 ng/ml were significantly lower than those in the group of visfatin ≥ 43.5 ng/ml (P < 0.01). The 24-hour DBPV, 24-hour SBPV and visfatin in group A-FABP < 20.9 ng/ml were significantly lower than those in group A-FABP ≥ 20.9 ng/ml (P < 0.01). 24 hSBPV was positively correlated with age, LDL-C, serum visfatin and serum A-FABP, and the difference was statistically significant (all P < 0.01). 24 hDBPV was positively correlated with age, serum visfatin and serum A-FABP (all P < 0.01).
        CONCLUSION  Age, A-FABP and visfatin are positively correlated with the increase of BPV, while BPV is closely correlated with target organ damage in elderly patients with hypertension.

       

    /

    返回文章
    返回